Parallel Advisors, LLC Oric Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	BUY	$6.05 - $9.28 $0 - $0	0 New	0 $0
Q3 2023 Nov 13, 2023	BUY	$6.05 - $9.28 $0 - $0	0 New	0 $0
Q1 2022 Apr 28, 2022	SELL	$4.54 - $16.1 $2,851 - $10,110	-628 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$12.01 - $20.3 $7,518 - $12,707	626 Added 31300.0%	628 $9,000
Q3 2021 Nov 02, 2021	BUY	$15.9 - $25.22 $31 - $50	2 New	2 $0

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.